Starting today and culminating on March 19th at the Center for Global Development, we hope you’ll join a conversation along with experts from implementing agencies, governments, research institutions, and the private sector to discuss and debate what makes a “best buy” in global health.
Administrator Raj Shah this week helped deliver the first liter of clean drinking water under a Global Development Alliance (GDA) between the US Agency for International Development (USAID) and Procter & Gamble (P&G) to improve health in Myanmar.
Over the next two years, USAID and P&G will make joint investments of at least $2 million on health projects aimed at providing clean drinking water through provision of P&G Purifier of Water packets, promoting better hygiene behaviors;,and building capability to deliver improved health services to mothers and children. These projects will be implemented on the ground by PSI.
With nearly 170 participants registered, 21 countries represented, countless organizations and specialties and the loud buzz of excited conversation, the first ever Unclogging the Blockages in Sanitation workshop in Kampala got off to a great start. Day 1′s goal was to Understand the Blockages: an entire day dedicated to informing participants of the challenges faced within the sanitation sector.
Despite growing attention to sanitation being paid by donors and governments, and the declaration by the United Nations that access to basic sanitation is a human right, progress remains slow. In an effort to get things moving (pun intended), on Tuesday, February 18, the first ever Unclogging the Blockages in Sanitation workshop will commence in Kampala, Uganda.
A quick explainer video for the Equity Measurement Toolkit, which was launched earlier this year.
By Kim Longfield, Director, Research & Metrics
In collaboration with the University of California, San Francisco (UCSF) and Johns Hopkins University, PSI has launched a new report: “Private Sector Healthcare in Myanmar: Evidence from the ‘Sun’ Social Franchise.” The report outlines how PSI reaches those most in need, especially in rural Myanmar, where healthcare options are limited or nonexistent.
For low-income populations, especially in Myanmar, private providers are the main source of medical care. Social franchising uses commercial franchising strategies to respond to the health needs of these communities. It builds on the existing private sector infrastructure and strengthens the capacity of private clinics, pharmacies, and community health workers to deliver quality services.
PSI is one of the largest providers of health products and services in Myanmar, in large part, due to its social franchising network of private healthcare providers. PSI/Myanmar’s Sun Quality network is comprised of Sun Quality Health (SQH), which serves urban and peri-urban areas, and Sun Primary Health (SPH), which serves rural regions. For providers, this model of healthcare offers trainings, subsidized products, quality assurance, common branding, and demand generation activities. For the people of Myanmar, it expands their choice of qualified providers who can address their most pressing health needs and are accessible in their communities.
By Christopher Purdy, Executive Vice President of DKT International. This originally appeared on The Broker blog.
If we want to increase jobs and reduce poverty, we must emphasize markets and the private sector, and include them in the post-2015 development discussion. Failure to engage the private sector in development is like trying to swim from New York to Amsterdam; you can do it but everyone else will have already arrived before you.
There is little doubt about the influence the private sector has on economies and societies. According to the Overseas Development Institute (ODI), the flow of foreign private investment into the developing world dwarfs official development assistance (ODA) by about 4 to 1, even in the aftermath of the global economic recession.
Like the public and NGO sectors, the private sector is far from perfect. And the underlying motive of generating profits does not always align well with humanitarian principles of development. However, there are an equal number of positive examples of how the private sector is helping to improve lives in the developing world. Indeed, broad development is severely impeded without active participation from a vibrant private sector. InterAction, the US consortium of international NGOs, echoed this sentiment in a 2011 policy paper which encouraged the US government and other donors to engage private sector actors not only in fundraising but also in the innovation and creativity that can promote better development.
By Christine Dugay, Development Analyst, and Pete Trolio, Director, Global Advisory and Analysis for Devex
There is considerable excitement regarding the role that corporations and their foundations are playing in global health. PSI and other prominent global health organizations are expecting this trend to continue and are counting on the private sector, particularly large multinational companies, to implement innovative and scalable health programs, establish new partnerships, and provide much-needed funding to catalyze sustainable change.
In order for organizations and individuals to engage with these companies, the global development community still requires a better understanding of exactly how multinationals are contributing to global health. The short and easy answer is that, in recent years, corporations have supported a wide range of initiatives across the global health value chain, from research and development to manufacturing and supply, and to direct delivery of products and services in various areas of the developing world.
A more detailed answer can be uncovered through an analysis of two major global industries, which are perhaps more involved in social development than any others: pharmaceuticals and oil. Here, Devex assesses the 2011 financial commitments, strategies and programs of three leading pharmaceutical companies – Pfizer, Merck and GlaxoSmithKline PLC – and three major oil companies – Exxon Mobil Corp., Chevron and Royal Dutch Shell PLC – all of which are positioning themselves as private sector philanthropic leaders through social investment and global health spending.
Justine Greening was appointed the United Kingdom’s Secretary for International Development in September 2011 to advance the government’s value-for-money agenda. She spoke with Impact about the U.K.’s global health strategy and how the participation of the private sector is essential to deliver the plan in the post-MDG 2015 era.
Impact: The U.K. government’s global health strategy focuses on three key areas: global health security, international development and trade for better health. Why?
Justine Greening: The “Health is Global” strategy published in 2011 sets out the responsibilities which government departments (beyond the Department of Health) have for delivering health outcomes in the U.K. and internationally. The refreshed strategy shows clear outcomes for research, the management of pandemic flu, health in conflict situations and priorities for improving health in the poorest countries. This is helping departments to invest their efforts in more concrete goals with the greatest impact.
For DFID, this means investing in health programs and research to improve the lives of the very poorest people. For example, we have committed to providing an additional 24 million women access to family planning by 2020, averting 20 million unwanted pregnancies and saving the lives of 42,000 girls and women. And by investing in research and development and countries’ health systems, we are helping the poorest people get access to life-saving medicines.